REVIVO Dual Summit 1927/1550nm Clinical Paper
REVIVO™ Dual Summit 1927/1550 Fractional Laser System
Clinical White Paper
Overview
Non ablative fractional laser technology has become a cornerstone in modern dermatology because it offers meaningful skin rejuvenation with minimal downtime and a strong safety profile compared to ablative resurfacing. The REVIVO™ Dual Summit 1927/1550 Fractional Laser System builds upon the extensively validated principles behind the Fraxel Dual platform by combining two clinically proven wavelengths in a single system: the 1550 nm erbium glass wavelength for deep dermal collagen remodeling, and the 1927 nm thulium wavelength for epidermal and superficial dermal resurfacing.
The system introduces an advanced Dual Mode function that allows both wavelengths to be delivered simultaneously. This enhances treatment synergy by opening superficial channels with 1927 nm while driving deeper thermal remodeling with 1550 nm, producing stronger and more comprehensive rejuvenation in a single session.
About the Device
The REVIVO™ Dual Summit is a professional non ablative fractional laser system designed for both superficial and deep skin improvement.
Wavelength Options
• 1550 nm Erbium Fiber Laser: penetrates approximately 300 to 1500 microns into the dermis and supports dermal remodeling, wrinkle reduction, and scar improvement.
• 1927 nm Thulium Fiber Laser: penetrates approximately 200 to 300 microns and is ideal for pigmentation, melasma management strategies, actinic keratosis, and superficial texture refinement.
• Dual Mode (1550 nm and 1927 nm simultaneously): enhances treatment efficiency and vertical coverage by combining superficial microchannel creation with deeper thermal stimulation.
Key System Features
• Spot sizes from 6 x 6 mm to 20 x 20 mm
• Fractional and continuous motion handpieces
• Adjustable pulse width, energy, and density
• Vaginal rejuvenation mode with customizable patterns
• Air and solid state cooling
• Safety interlocks and spot recognition
• Built in disinfection chamber
• No consumable cards or shot limits
Science Behind the Technology
Fractional photothermolysis creates microscopic thermal zones that trigger a controlled healing response while preserving the surrounding tissue. This stimulates collagen production, improves elasticity, and enhances the overall appearance of the skin.
Key wavelength actions
• 1550 nm wavelength: penetrates deeper layers of the dermis, improves texture and wrinkles, supports collagen remodeling, and treats acne scars.
• 1927 nm wavelength: targets the epidermis and upper dermis, making it highly effective for pigmentation, actinic keratoses, melasma management protocols, and superficial texture issues.
• Dual Mode synergy: combines superficial channel formation from 1927 nm with deeper dermal remodeling from 1550 nm. Research on dual wavelength systems shows that this two level approach produces more uniform, efficient, and enhanced results compared to using either wavelength alone.
Clinical Evidence from Peer Reviewed Literature
The wavelengths used in the REVIVO™ Dual Summit have been well studied through Fraxel Dual research. More than fifty published studies support the effectiveness of 1550 nm and 1927 nm non ablative fractional systems for a range of dermatologic indications.
Friedman et al. – Dermatologic Surgery
• Dual wavelength systems demonstrated strong efficacy across all Fitzpatrick skin types.
• 1550 nm improved deeper structural concerns including scars, wrinkles, and dermal pigmentation.
• 1927 nm effectively treated actinic keratoses and superficial pigmentation.
• Combined wavelength use improved resurfacing outcomes and clinical consistency.
• Lower density settings were recommended to reduce PIH risk in darker skin types.
Chang and Lim – Medical Lasers
• 1550 nm improved dermal thickness, texture, and scars.
• 1927 nm improved epidermal tone, pigmentation, and superficial textural irregularities.
• Combined treatments offered stronger overall rejuvenation.
• Side effects were mild and temporary in most cases.
Tanzi et al. – Aesthetic Surgery Journal
• Long term improvement in acne scars and photodamage with 1550 nm non ablative resurfacing.
• Continued collagen remodeling over several months contributed to sustained results.
• Downtime was significantly less compared to ablative CO2 resurfacing.
Expected Clinical Outcomes With REVIVO™
Practitioners can expect a range of clinical improvements supported by established fractional laser research.
Skin rejuvenation
• Smoother texture
• Reduced fine lines
• Enhanced radiance
• Firmer and more even appearance
Scar remodeling
• Improved acne scars
• Smoother surgical and traumatic scars
• Reduction of discoloration within scars
Pigmentation correction
• Reduction in sun damage and age spots
• Improved melasma management (with conservative settings)
• Correction of epidermal and superficial dermal pigment
Pore refinement and oil balance
• Smaller appearing pores
• Improved sebum regulation
Hair restoration support
• Enhanced follicle stimulation when combined with topical therapies
Intimate wellness (optional handpiece)
• Vaginal tightening
• Vulva rejuvenation
• Support for stress urinary incontinence treatment protocols
Safety Profile
Non ablative fractional lasers have a strong safety record. Expected temporary effects include mild redness, swelling, bronzing, and light flaking as microchannels heal. PIH risk can be minimized by using lower densities and correct pre and post care, especially for higher Fitzpatrick skin types.
REVIVO™ includes safety features such as:
• Integrated cooling
• Controlled energy delivery
• Density and spot recognition
• Safety interlocks
• Built in disinfection chamber
These features support safe operation across a wide range of treatments.
Conclusion
Clinical evidence strongly supports the use of 1550 nm and 1927 nm non ablative fractional lasers for skin rejuvenation, pigmentation correction, scar remodeling, and several dermatologic applications. The REVIVO™ Dual Summit expands on this proven foundation by enabling simultaneous dual wavelength output, offering multiple spot sizes, an ergonomic roller handpiece, and optional intimate wellness capabilities. These enhancements allow practitioners to achieve comprehensive, predictable, and efficient results with minimal downtime.
References
- Friedman PM et al. Dermatol Surg. 2022.
- Chang HS, Lim NK. Med Lasers. 2020.
- Tanzi EL, Wanitphakdeedecha R, Alster TS. Aesthetic Surgery Journal. 2008.
- Manstein D et al. Lasers Surg Med. 2004.
- Weiss ET et al. J Am Acad Dermatol. 2013.
- Kurmuş G et al. J Cosmet Laser Ther. 2019.
- Niwa Massaki ABM et al. Lasers Surg Med. 2013.
- Glaich AS et al. Arch Dermatol. 2007.
- FDA Registration Database – Rejuva Fresh LLC (REVIVO Dual 1927/1550 and REVIVO Dual Summit 1927/1550, Product Codes GEX and ONF, K240474).